Diagnostic Products Archives

Cat #: 13080010
BCL1/J_H Translocation Assay for Gel Detection
BACKGROUND This aberrant BCL1/JH t(11;14) translocation juxtaposes genes of the immunoglobulin heavy chain (IGH) gene on chromosome 14q32 with the cyc...
View Product
Cat #: 23080010
BCL1/J_H Tube – Unlabeled for Gel Detection
The aberrant BCL1/JH t(11;14) translocation juxtaposes genes of the immunoglobulin heavy chain (IGH) gene on chromosome 14q32 with the cyclin D1 gene ...
View Product
Cat #: 13080020
BCL1/JH Translocation Assay MegaKit for Gel Detection
BACKGROUND This aberrant BCL1/JH t(11;14) translocation juxtaposes genes of the immunoglobulin heavy chain (IGH) gene on chromosome 14q32 with the cyc...
View Product
Cat #: A3090060
BCL2/J_H 3’Mbr – Unlabeled
This product targets the human BCL2/JH fusion gene. ...
View Product
Cat #: A3090050
BCL2/J_H Mbr – Unlabeled
This product targets the human BCL2/JH fusion gene. ...
View Product
Cat #: A3090070
BCL2/J_H mcr – Unlabeled
This product targets the human BCL2/JH fusion gene. ...
View Product
Cat #: 13090010
BCL2/J_H t(14;18) Translocation Assay for Gel Detection
BACKGROUND BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant trans...
View Product
Cat #: 13090020
BCL2/J_H Translocation Assay for Gel Detection
BACKGROUND BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant trans...
View Product
Cat #: 13090040
BCL2/J_H Translocation Assay MegaKit for Gel Detection
BACKGROUND BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant trans...
View Product
Cat #: 23090050
BCL2/J_H Tube A – Unlabeled for Gel Detection
BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant transcriptional ...
View Product
Cat #: 23090060
BCL2/J_H Tube B – Unlabeled for Gel Detection
BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant transcriptional ...
View Product
Cat #: 23090070
BCL2/J_H Tube C – Unlabeled for Gel Detection
BCL2 translocations are reciprocal chromosome exchanges that place the bcl-2 proto-oncogene, located on chromosome 18, under aberrant transcriptional ...
View Product
Cat #: 40850310
BCR/ABL b2a2 RNA Dilution Set
Invivoscribe’s BCR/ABL b2a2 RNA Dilution Set consists of RNA that has been extracted from established BCR/ABL b2a2 positive and BCR/ABL negati...
View Product
Cat #: 40850210
BCR/ABL b3a2 RNA Dilution Set
Invivoscribe’s BCR/ABL b3a2 RNA Dilution Set consists of RNA that has been extracted from established BCR/ABL b3a2 positive and BCR/ABL negati...
View Product
Cat #: 40850110
BCR/ABL e1a2 RNA Dilution Set
Invivoscribe’s BCR/ABL e1a2 RNA Dilution Set consists of RNA that has been extracted from established BCR/ABL e1a2 positive and BCR/ABL negati...
View Product
Cat #: 13100031
BCR/ABL t(9;22) Translocation Assay for ABI Fluorescence Detection
BACKGROUND BCR/ABL translocations are associated with a variety of hematologic malignancies. The Philadelphia chromosome (Ph1) is a specific chromos...
View Product
Cat #: 13100010
BCR/ABL t(9;22) Translocation Assay for Gel Detection
BACKGROUND BCR/ABL translocations are associated with a variety of hematologic malignancies. The Philadelphia chromosome (Ph1) is a specific chromos...
View Product
Cat #: 24120010
FLT3 ITD Master Mix – Unlabeled for Gel Detection
FLT3 is a receptor tyrosine kinase that is normally expressed on many cell types including hematologic stem cells. Mutation of the FLT3 receptor, by...
View Product
Cat #: 14120019
FLT3 ITD MRD Assay
BACKGROUND Mutations in the fms-like tyrosine kinase 3 (FLT3) gene are the most prevalent mutations found in acute myeloid leukemia (AML) and are char...
View Product
Cat #: 14120031
FLT3 Mutation Assay – ABI Fluorescence Detection
BACKGROUND FLT3 is a receptor tyrosine kinase that is normally expressed on many cell types including hematologic stem cells. Mutation of the FLT3 r...
View Product
Cat #: 14120010
FLT3 Mutation Assay – Gel Detection
BACKGROUND FLT3 is a receptor tyrosine kinase that is normally expressed on many cell types including hematologic stem cells. Mutation of the FLT3 r...
View Product
Cat #: 11000031
IGH + IGK B-Cell Clonality Assay – ABI Fluorescence Detection
BACKGROUND Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products th...
View Product
Cat #: 11000010
IGH + IGK B-Cell Clonality Assay for Gel Detection
BACKGROUND Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products th...
View Product
Cat #: 11000041
IGH + IGK B-Cell Clonality Assay MegaKit – ABI Fluorescence Detection
BACKGROUND Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products th...
View Product
Cat #: A1010041
IGH DH1-6 – HEX
This product targets the diversity and joining regions of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010051
IGH DH7 – 6FAM
This product targets the diversity and joining regions of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010011
IGH FR1- 6FAM
This product targets the framework 1 region of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010101
IGH FR2 – 6FAM
This product targets the framework 2 region of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010020
IGH FR2 – Unlabeled
This product targets the framework 2 region of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010031
IGH FR3 – HEX
This product targets the framework 3 region of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010030
IGH FR3 – Unlabeled
This product targets the framework 3 region of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010061
IGH Framework 1 – 6FAM
This product targets the framework 1 region of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010091
IGH Framework 2 – 6FAM
This product targets the framework 2 region of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010070
IGH Framework 2 – Unlabeled
This product targets the framework 2 region of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010081
IGH Framework 3 – HEX
This product targets the framework 3 region of the human immunoglobulin heavy chain gene. ...
View Product
Cat #: A1010080
IGH Framework 3 – Unlabeled
This product targets the framework 3 region of the human immunoglobulin heavy chain gene. ...
View Product

Now Available

Our New Document Search Feature

SEARCH ⟶

Need Help Placing an Online Order?

Contact our Customer Service Team

CONTACT CUSTOMER SERVICE ⟶

Now Available

Our New Document Search Feature

SEARCH ⟶

Need Help Placing an Online Order?

Contact our Customer Service Team

CONTACT CUSTOMER SERVICE ⟶

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021 Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing